Intelligent Bio Solutions Inc.
INBS
$1.70
-$0.06-3.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.78% | 19.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.78% | 19.98% | |||
| Cost of Revenue | 31.17% | 0.81% | |||
| Gross Profit | -1.70% | 53.03% | |||
| SG&A Expenses | 12.90% | 33.08% | |||
| Depreciation & Amortization | -0.56% | -1.05% | |||
| Other Operating Expenses | -121.52% | -29.72% | |||
| Total Operating Expenses | 13.51% | 14.28% | |||
| Operating Income | -12.86% | -12.75% | |||
| Income Before Tax | -21.64% | -13.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.64% | -13.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 76.06% | -2.74% | |||
| Net Income | -21.49% | -13.07% | |||
| EBIT | -12.86% | -12.75% | |||
| EBITDA | -13.90% | -14.79% | |||
| EPS Basic | -0.18% | 11.13% | |||
| Normalized Basic EPS | 7.05% | 11.12% | |||
| EPS Diluted | -0.18% | 11.13% | |||
| Normalized Diluted EPS | 7.05% | 11.12% | |||
| Average Basic Shares Outstanding | 21.26% | 27.25% | |||
| Average Diluted Shares Outstanding | 21.26% | 27.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||